American Association for the Advancement of Science, Science Translational Medicine, 444(10), 2018
DOI: 10.1126/scitranslmed.aan8162
Export citation
Search in Google Scholar
Full text: Unavailable
A LRRK2 inhibitor ameliorates intestinal inflammation in a mouse model of colitis.